CASIA OpenIR

Browse/Search Results:  1-5 of 5 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer 期刊论文
NANOSCALE, 2018, 卷号: 10, 期号: 35, 页码: 16738-16749
Authors:  Li, Yuan;  Du, Yang;  Liang, Xiaolong;  Sun, Ting;  Xue, Huadan;  Tian, Jie;  Jin, Zhengyu
Favorite  |  View/Download:11/0  |  Submit date:2019/01/08
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model 期刊论文
BMC Cancer, 2018, 卷号: 18, 期号: 1, 页码: 669
Authors:  Li Yuan;  Du Yang;  Sun Ting;  Xue Huadan;  Jin Zhengyu;  Tian Jie
View  |  Adobe PDF(4369Kb)  |  Favorite  |  View/Download:18/6  |  Submit date:2019/02/18
Pd-1, Zoledronic Acid, Breast Cancer, Therapy, Checkpoint Inhibitior  
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model 期刊论文
BMC CANCER, 2018, 卷号: 18
Authors:  Li, Yuan;  Du, Yang;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
Favorite  |  View/Download:28/0  |  Submit date:2018/10/10
Pd-1  Zoledronic Acid  Breast Cancer  Therapy  Checkpoint Inhibitior  
Liposomal Nanohybrid Cerasomes Targeted to PD-L1 Enable Dual-Modality Imaging and Improve Antitumor Treatments 期刊论文
Cancer Letters, 2018, 期号: 414, 页码: 230-238
Authors:  Du Yang;  Xiaolong Liang;  Yuan Li;  Ting Sun;  Huadan Xue;  Zhengyu Jin;  Jie Tian
Favorite  |  View/Download:6/0  |  Submit date:2019/02/18
Programmed Cell Death Ligand-1, Near Infrared FLuorescence, Magnetic Resonance Imaging, Paclitaxel, Chemotherapy, Immunotherapy  
Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments 期刊论文
CANCER LETTERS, 2018, 卷号: 414, 期号: 414, 页码: 230-238
Authors:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
View  |  Adobe PDF(3002Kb)  |  Favorite  |  View/Download:125/51  |  Submit date:2018/01/03
Programmed Cell Death Ligand-1  Near Infrared Fluorescence  Magnetic Resonance Imaging  Paclitaxel  Chemotherapy  Immunotherapy